Novozymes A/S OTC:NVZMY

Novozymes A/S stock price today

$65.53
+8.21
+14.32%
Financial Health
0
1
2
3
4
5
6
7
8
9

Novozymes A/S stock price monthly change

-8.26%
month

Novozymes A/S stock price quarterly change

-8.26%
quarter

Novozymes A/S stock price yearly change

+3.30%
year

Novozymes A/S key metrics

Market Cap
14.86B
Enterprise value
201.72B
P/E
53.96
EV/Sales
8.87
EV/EBITDA
45.04
Price/Sales
8.31
Price/Book
1.38
PEG ratio
0.13
EPS
10.92
Revenue
17.89B
EBITDA
4.63B
Income
3.02B
Revenue Q/Q
1.63%
Revenue Y/Y
1.97%
Profit margin
9.29%
Oper. margin
15.67%
Gross margin
46.67%
EBIT margin
15.67%
EBITDA margin
25.9%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Novozymes A/S stock price history

Novozymes A/S stock forecast

Novozymes A/S financial statements

Novozymes A/S (OTC:NVZMY): Profit margin
Mar 2023 4.62B 784M 16.96%
Jun 2023 4.21B 606M 14.37%
Sep 2023 4.45B 936M 21.01%
Dec 2023 4.60B 698M 15.16%
Novozymes A/S (OTC:NVZMY): Analyst Estimates
2025 30.87B 3.92B 12.7%
2026 33.04B 4.34B 13.14%
2027 35.21B 4.64B 13.2%
2028 38.03B 4.88B 12.84%
  • Analysts Price target

  • Financials & Ratios estimates

1.02%
Yield TTM
Novozymes A/S (OTC:NVZMY): Payout ratio
Payout ratio 100.71%
Novozymes A/S (OTC:NVZMY): Dividend Yield
2019 1.55%
2020 1.52%
2021 0.97%
2022 1.57%
2023 2.77%
Novozymes A/S (OTC:NVZMY): Debt to assets
Mar 2023 28284000000 14.99B 53.03%
Jun 2023 28228000000 14.42B 51.12%
Sep 2023 28538000000 13.64B 47.82%
Dec 2023 28391000000 14.04B 49.45%
Novozymes A/S (OTC:NVZMY): Cash Flow
Mar 2023 314M -339M 99M
Jun 2023 1.13B -705M -456M
Sep 2023 1.58B -486M -977M
Dec 2023 1.12B -603M -555M

Novozymes A/S alternative data

Novozymes A/S (OTC:NVZMY): Employee count
Aug 2023 6,790
Sep 2023 6,852
Oct 2023 6,852
Nov 2023 6,820
Dec 2023 6,820
Jan 2024 6,820
Feb 2024 6,820
Mar 2024 6,397
Apr 2024 6,397
May 2024 6,397
Jun 2024 6,397
Jul 2024 6,397

Novozymes A/S other data

Sunday, 10 November 2024
seekingalpha.com
Friday, 8 November 2024
seekingalpha.com
Monday, 4 November 2024
zacks.com
Friday, 4 October 2024
zacks.com
Tuesday, 1 October 2024
zacks.com
Friday, 30 August 2024
zacks.com
Thursday, 29 August 2024
zacks.com
Wednesday, 28 August 2024
seekingalpha.com
Tuesday, 23 July 2024
zacks.com
Monday, 22 July 2024
zacks.com
Wednesday, 17 April 2024
Zacks Investment Research
Monday, 1 April 2024
Zacks Investment Research
Tuesday, 19 March 2024
Zacks Investment Research
Thursday, 14 March 2024
Zacks Investment Research
Friday, 1 March 2024
Zacks Investment Research
Tuesday, 27 February 2024
Zacks Investment Research
Thursday, 1 February 2024
Seeking Alpha
Wednesday, 17 January 2024
CNBC International TV
Wednesday, 6 December 2023
Reuters
Wednesday, 22 November 2023
Zacks Investment Research
Thursday, 9 November 2023
Proactive Investors
Monday, 6 November 2023
Zacks Investment Research
Thursday, 26 October 2023
CNBC International TV
Wednesday, 11 October 2023
Zacks Investment Research
Tuesday, 10 October 2023
Seeking Alpha
Friday, 22 September 2023
Zacks Investment Research
Wednesday, 16 August 2023
Zacks Investment Research
Wednesday, 9 August 2023
Seeking Alpha
Seeking Alpha
Wednesday, 12 July 2023
Zacks Investment Research
  • What's the price of Novozymes A/S stock today?

    One share of Novozymes A/S stock can currently be purchased for approximately $65.53.

  • When is Novozymes A/S's next earnings date?

    Novozymes A/S is estimated to report earnings on Wednesday, 13 Aug 2025.

  • Does Novozymes A/S pay dividends?

    Yes, Novozymes A/S pays dividends and its trailing 12-month yield is 1.02% with 101% payout ratio.It means that the company is paying a dividend greater than earnings. The last Novozymes A/S stock dividend of undefined was paid on 6 Sep 2025.

  • How much money does Novozymes A/S make?

    Novozymes A/S has a market capitalization of 14.86B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1.97% to 17.9B US dollars.

  • What is Novozymes A/S's stock symbol?

    Novozymes A/S is traded on the OTC under the ticker symbol "NVZMY".

  • What is Novozymes A/S's primary industry?

    Company operates in the Basic Materials sector and Specialty Chemicals industry.

  • How do i buy shares of Novozymes A/S?

    Shares of Novozymes A/S can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Novozymes A/S have?

    As Jul 2024, Novozymes A/S employs 6,397 workers.

  • When Novozymes A/S went public?

    Novozymes A/S is publicly traded company for more then 6 years since IPO on 30 Nov 2018.

  • What is Novozymes A/S's official website?

    The official website for Novozymes A/S is novozymes.com.

  • How can i contact Novozymes A/S?

    Novozymes A/S can be reached via phone at +45 44 46 00 00.

Novozymes A/S company profile:

Novozymes A/S

novozymes.com
Exchange:

OTC

Full time employees:

6,438

Industry:

Specialty Chemicals

Sector:

Basic Materials

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers baking, beverages, dairy, starch, and protein solutions for the food and beverage industry; laundry, dishwashing, and professional cleaning solutions for the household care industry; agriculture solutions, including crop production, and animal health and nutrition solutions; bioyield and biocontrol solutions for crops; and grain and technical processing solutions, as well as bio energy solutions for liquefaction, saccharifaction, fermentation, fiber conversion, and biomass conversion. It also provides textile solutions, such as biopreparation, biopolishing, bleach clean-up, denim abrasion and finishing, and desizing solutions. In addition, the company offers solutions for pulp & paper, including fiber modification, bleach boosting, deposit control, starch modification, and deinking; leather solutions comprising acid bating, area expansion, bating, degreasing, soaking, and unhairing and liming; and water and waste management solutions, which consist of bioaugmentation, biogas, and sludge management. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis, as well as rTrypsin for cell culture; and human health and protein solutions. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.

Krogshoejvej 36
Bagsvaerd, 2880

:
ISIN: US6701081092
CUSIP: 670108109